Loading
Loading
We use strictly necessary cookies to run this site, and analytics cookies to understand how it's used. See our Privacy Policy for details.
45 CFR §164.308(a)(1)(ii)(A)'s risk analysis mandate, why OCR keeps citing it as the top audit deficiency, and where testing fits as evidence.
The single most common HIPAA Security Rule deficiency the HHS Office for Civil Rights finds in audits and breach investigations isn't a missing firewall rule or an unpatched server — it's an inadequate or missing risk analysis. That's a specific, named legal requirement, not general security best practice, and it's the real starting point for understanding where penetration testing actually fits into HIPAA compliance.
The requirement sits at 45 CFR §164.308(a)(1)(ii)(A), part of the Security Management Process standard: every covered entity and business associate that creates, receives, maintains, or transmits electronic protected health information (ePHI) must "conduct an accurate and thorough assessment of the potential risks and vulnerabilities to the confidentiality, integrity, and availability" of that ePHI. It's the foundational requirement the rest of the Security Rule's safeguards are supposed to be built on — every other control is meant to be implemented based on what the risk analysis actually finds, not applied generically.
HIPAA does the same thing NIS2, DORA, and ISO 27001 all do: it describes a risk-management outcome, not a specific testing method. Nowhere does the Security Rule name penetration testing explicitly as a requirement — the same pattern we cover in what ISO 27001's Annex A.8.29 actually requires. What it requires is a thorough, accurate assessment of risk to ePHI, and penetration testing is one of the more credible ways an organization actually produces that evidence for a system handling real patient data, rather than a paper exercise based on assumptions about what could go wrong.
HHS's own guidance is direct about this: risk analysis deficiencies are the most frequently cited Security Rule failure in both OCR's compliance audits and its post-breach investigations. In practice, that usually means one of two things — the risk analysis was never actually performed on the real, current environment (a copy-pasted template from a prior year, or from a different organization entirely), or it was performed but never actually informed which safeguards got prioritized afterward. A risk analysis that doesn't change what an organization actually does isn't evidence of compliance, however thorough the document looks.
For an organization with real, valuable ePHI exposure — a hospital system, a health-tech platform, a claims processor — a risk analysis built only on documentation review and interviews is thinner evidence than one informed by actual testing of the systems that touch ePHI. Manual testing surfaces the gap between what a system is supposed to do and what it actually does under adversarial pressure, which is exactly the kind of concrete finding a risk analysis is supposed to identify. This is the same reasoning behind why manual testing catches what automated scanning alone misses — a risk analysis leaning entirely on a vulnerability scanner's output inherits the same blind spots that scanner has everywhere else it's used.
Testing scoped around a HIPAA risk analysis needs to actually reach the systems where ePHI genuinely lives — EHR integrations, patient portals, billing systems, and any third-party vendor connection handling PHI on the organization's behalf, since business associate exposure is explicitly in scope under the Security Rule too. A generic external network test that never touches the actual application layer where PHI is processed produces a risk analysis with a real gap in it, however clean the report looks.
If your organization's risk analysis needs to be genuinely current and evidence-based rather than a template exercise, that's exactly what real testing is for. Our Penetration Testing service and Cybersecurity Consulting team can help scope an assessment that actually reaches your PHI-handling systems and produces findings a risk analysis can be built on — not a substitute for your own compliance and legal review, but the technical evidence that review depends on.
Tell us about your environment and goals — we'll help you scope the right engagement.